Z4D.SI up 9.09% to S$0.012 on 20 Jan 2026: Market Closed, grade and forecast
Z4D.SI stock rose 9.09% to S$0.012 on 20 Jan 2026 as the SES session closed, making Medi Lifestyle Limited a top gainer in the Healthcare sector on Singapore exchanges. Trading volume reached 302,000 shares on the day versus an average of 934,611, signalling above-average interest. Meyka AI’s real-time platform flags the move and notes short-term momentum with an RSI 63.70. We summarise the price drivers, valuation, and analyst-grade context for investors tracking this small-cap healthcare name on the SES.
Z4D.SI stock price action and volume
Z4D.SI stock closed at S$0.012 on 20 Jan 2026 after a session high of S$0.013 and a low of S$0.011. Volume was 302,000.00 versus an average of 934,611.00, giving a relative volume of 0.41 and confirming the stock was a top gainer by percentage on the SES that day. The one-day change of +9.09% followed a 3-month gain of 9.09% and a 6-month gain of 20.00%, showing recent positive momentum.
Fundamentals and valuation snapshot for Z4D.SI stock
Medi Lifestyle Limited reports an EPS of -0.01 and a PE of -1.20, reflecting current losses. Market capitalisation stands at S$1,929,629.00 with 160,802,419 shares outstanding. Price averages are 50-day: S$0.01068 and 200-day: S$0.00899, which places the current S$0.012 above both moving averages. Price-to-sales is 1.13 and book value per share is negative at -0.01, signalling a thin balance sheet and challenges in tangible equity.
Technical indicators and trading signals
Technicals show a short-term bullish tilt: RSI 63.70, ADX 42.80 indicating a strong trend, and MFI 93.98 suggesting overbought conditions. Bollinger Bands sit near S$0.010 middle band and the On-Balance Volume supports recent inflows. Traders should note low liquidity risks: daily volume is below the stock’s 50-day average, and the bid-ask spread on small-cap SES names can widen quickly.
Meyka AI grade and analyst context
Meyka AI rates Z4D.SI with a score out of 100: 62.70 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The platform classifies risks around negative earnings, tight current ratio 0.52, and negative book value, while noting revenue per share of 0.03 and a recent uptick in momentum.
Meyka AI’s forecast model projects near- and long-term targets
Meyka AI’s forecast model projects monthly: S$0.010, quarterly: S$0.020, and yearly: S$0.03986. Compared with the current price of S$0.012, implied moves are -16.67% (monthly), +66.67% (quarterly), and +232.20% (yearly). The model also shows a 3-year target S$0.09295 (implied +674.62%). Forecasts are model-based projections and not guarantees. Investors should treat long-term forecasts as high variance given the company’s small market cap and thin liquidity.
Catalysts, risks and sector context
Medi Lifestyle operates in Medical – Care Facilities and competes with larger SES healthcare names. Sector average PE is 22.08, while Medi Lifestyle posts a negative PE. Catalysts include higher postpartum service demand and commodity trading margins. Key risks are low cash per share S$0.0018, negative operating cash flow per share -0.0235, and concentration of revenue streams. Sector performance has been mixed; healthcare names saw a 1Y +22.76% average, but small-caps remain volatile.
Final Thoughts
Z4D.SI stock led SES intraday gainers on 20 Jan 2026, closing at S$0.012 with a +9.09% move and 302,000.00 shares traded. The short-term technical picture is bullish but shows overbought signals, and fundamentals point to negative earnings and a delicate balance sheet. Meyka AI rates the stock 62.70/100 (Grade B, HOLD) and provides model-based targets showing a yearly forecast S$0.03986 (implied +232.20%) and a three-year projection of S$0.09295 (implied +674.62%). These forecasts illustrate the high upside scenario but come with high model risk given low liquidity and negative cash flow metrics. For active traders, watch intraday volume, RSI, and news on the NADORA and Back to Life brands. For longer-term investors, the stock requires proof of consistent revenue growth and margin improvement before a BUY stance is appropriate. For the full quote and live updates, see our Meyka stock page and follow verified news links for company developments.
FAQs
What drove the Z4D.SI stock jump on 20 Jan 2026?
The S$0.012 close and 9.09% gain came on higher-than-average volume (302,000) and short-term momentum signals like RSI 63.70. Small-cap liquidity amplified the move rather than a single major corporate announcement.
What is Meyka AI’s view on Z4D.SI stock?
Meyka AI assigns Z4D.SI a score of 62.70 out of 100 (Grade B, HOLD). The rating balances recent momentum against negative earnings and weak cash metrics, noting the stock is speculative.
What are realistic price targets for Z4D.SI stock?
Meyka AI’s model projects quarterly S$0.020 and yearly S$0.03986. These imply +66.67% and +232.20% versus S$0.012. Forecasts are model-based projections and not guarantees.
What key risks should investors watch for Z4D.SI stock?
Monitor negative operating cash flow per share (-0.0235), a low current ratio (0.52), negative book value, and thin trading volumes that can widen spreads and increase price volatility.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
